Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 4/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CCR3 | P51677 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28496876 | 0.89 | CA1 (0.43) | GBA1MAOBHTR1ASIGMAR1DDB1 | |
| SCHEMBL7977009 | 0.82 | CHRM5 (0.47) | GBA1MAOBHTR1ASIGMAR1CYP19A1 | |
| SCHEMBL5236823 | 0.82 | CHRM5 (0.47) | GBA1MAOBHTR1ASIGMAR1CYP19A1 | |
| SCHEMBL5859935 | 0.82 | CHRM5 (0.47) | GBA1MAOBHTR1ASIGMAR1CYP19A1 | |
| SCHEMBL9236758 | 0.82 | MAOB (0.40) | MAOBCYP19A1TAAR1 | |
| SCHEMBL5675291 | 0.76 | GBA1 (0.57) | GBA1HTR1ASIGMAR1DDB1CRBN | |
| SCHEMBL8772735 | 0.74 | GBA1 (0.46) | GBA1MAOBHTR1ASIGMAR1CCR3 | |
| SCHEMBL4865573 | 0.73 | GBA1 (0.48) | GBA1HTR1ASIGMAR1DDB1CRBN | |
| SCHEMBL4865561 | 0.73 | GBA1 (0.48) | GBA1HTR1ASIGMAR1DDB1CRBN | |
| SCHEMBL12040400 | 0.72 | CRBN (0.53) | GBA1DDB1CRBNCYP19A1CCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112107690-B | Preparation method of camptothecine drug nanoparticles | 浙江工业大学 | 2023-05-30 | — | — | CN | claimed |
| CN-112107690-B | Preparation method of camptothecine drug nanoparticles | 浙江工业大学 | 2023-05-30 | — | — | CN | disclosed |
| EP-3150578-B1 | NOVEL PYRROLIDINE COMPOUND AND APPLICATION AS MELANOCORTIN RECEPTOR AGONIST | MITSUBISHI TANABE PHARMA CORP (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-8440608-B2 | Beta-substituted tetrandropyrana (on) s and method for the synthesis and the use thereof | V. MANE FILS (FR) | 2013-05-14 | — | — | US | disclosed |
| EP-1773284-B1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THEIR USE IN PERFUMERY | MANE FILS V (FR) | 2010-09-15 | — | — | EP | disclosed |
| CN-100508941-C | Beta-substituted tetrahydropyrans (ketones), method for the synthesis thereof and use thereof | MANE FILS V (FR) | 2009-07-08 | — | — | CN | disclosed |
| US-20080032914-A1 | Beta-Substituted Tetrahdropyrana (On) S And Method For The Synthesis And The Use Thereof | V. MANE FILS (FR) | 2008-02-07 | — | — | US | disclosed |
| CN-101001605-A | Beta-substituted tetrahydropyran(on)s and method for the synthesis and the use thereof | MANE FILS V (FR) | 2007-07-18 | — | — | CN | disclosed |
| EP-1773284-A1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THE USE THEREOF | V. Mane Fils (FR) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006021663-A1 | BETA-SUBSTITUTED TETRAHYDROPYRAN(ON)S AND METHOD FOR THE SYNTHESIS AND THE USE THEREOF | V. MANE FILS (FR) | 2006-03-02 | — | — | WO | disclosed |